Skip to main content
Premium Trial:

Request an Annual Quote

CRISPR Approach to Induce Exon Skipping in Dystrophin Gene

A dual CRISPR-Cas3 system could be used to induce multi-exon skipping to restore the open reading frame of the dystrophin gene, a new study has found. Duchenne muscular dystrophy, a severe degenerative muscle disorder, is caused by mutations in the dystrophin gene that disrupt its open reading frame, leading to the loss of functional dystrophin proteins. Researchers from Kyoto University have used CRISPR-Cas3 to induce a deletion of 340 kilobases that restores that reading frame, as they report in Stem Cell Reports. To generate a large deletion spanning exons 45 to 55 — a in-frame deletion here is associated with milder disease — they relied on a pair of inward-facing crRNAs. In HEK293T cell lines and in iPSCs, including patient-derived IPSCs, this approach could generate a large deletion with few off-target effects, the researchers report. "Our dual-Cas3 system might apply to future gene therapies once we're able to deliver the dual-Cas3 components in vivo to skeletal muscle tissues safely and efficiently," senior author Akitsu Hotta from Kyoto and the Takeda-CiRA Joint Program says in a statement. "The ability to induce several hundred kilobases of DNA deletion itself also has broad applicability for basic research when a large deletion is needed."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.